Trexquant Investment LP Centessa Pharmaceuticals PLC Transaction History
Trexquant Investment LP
- $8.35 Billion
- Q2 2025
A detailed history of Trexquant Investment LP transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Trexquant Investment LP holds 151,352 shares of CNTA stock, worth $3.45 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
151,352
Previous 263,994
42.67%
Holding current value
$3.45 Million
Previous $3.8 Million
47.63%
% of portfolio
0.02%
Previous 0.05%
Shares
7 transactions
Others Institutions Holding CNTA
# of Institutions
126Shares Held
122MCall Options Held
638KPut Options Held
146K-
Medicxi Ventures Management (Jersey) LTD20MShares$455 Million73.31% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$227 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$221 Million4.43% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.4MShares$192 Million0.2% of portfolio
-
Janus Henderson Group PLC London, X06.53MShares$149 Million0.04% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $2.15B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...